In the Media

July 4, 2022

Pharma Tech Outlook: InMed Introduces THCV Into the Health and Wellness Industry

InMed’s THCV will bring ample opportunity to the health sector to scale up in the market.

Read full story via Pharma Tech Outlook.

Share this post

Latest Articles

The Potential of Cannabinoids in the Treatment of Alzheimer’s Disease

InMed’s INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Promising early studies demonstrate INM-901’s neuroprotective effects and an ability

October 24, 2023

Benzinga Live Panel Discussion – Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are the Next Big Thing

Jerry Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, joins this live panel discussion “Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are

October 10, 2023

Podcast: Dr. Shane Johnson is guest on The Water Tower Hour (Live Recording from Benzinga Conference)

Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, is a guest on The Water Tower Hour podcast. Host Jesse Redmond, Senior Analyst at Water Tower

October 6, 2023